News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cequent Pharmaceuticals, Inc. Closes Tranche of $10.8 Million Round


11/2/2009 8:04:11 AM

Boston Business Journal -- Cambridge-based biotechnology company Cequent Pharmaceuticals has raised $2.7 million of a planned $10.8 million financing round. The funding included investments from Wellesley, Mass.-based Ampersand Ventures, New England Capital Partners in Newton, Mass., and Durham, N.C.-based A.M. Pappas Life Science Ventures.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES